ASX:4DXHealthcare Services
A Look At 4DMedical’s Valuation After New GlaxoSmithKline Imaging Contract
Why the new GlaxoSmithKline contract matters for 4DMedical
4DMedical (ASX:4DX) has drawn fresh attention after securing a one year engagement with GlaxoSmithKline to supply quantitative lung imaging analytics for pulmonary drug development and clinical research, in association with Flywheel Exchange.
Under the agreement, starting May 1, 2026, 4DMedical will provide advanced lung imaging biomarkers from its software analytics platform, supporting sensitive, quantitative assessment of lung...